HB 434 is a broad healthcare cost and transparency bill that revises multiple parts of North Carolina law affecting hospitals, ambulatory surgical facilities, insurers, healthcare providers, and the State Health Plan. The bill requires more detailed public reporting of hospital and ambulatory surgical facility prices, including charges, negotiated amounts, Medicare and Medicaid reimbursement, and insurer payment ranges for common inpatient, surgical, and imaging services. It also expands patient-facing disclosure requirements so insured patients are told when they may receive separate bills from nonparticipating providers or facilities, and it creates a right to a written good-faith estimate for shoppable services, with the final bill capped at no more than 5% above the estimate when requested in advance.
The bill also limits and regulates facility fees, barring them for certain outpatient services and requiring hospitals and health systems to report facility-fee revenue and related service data to DHHS. In addition, it strengthens billing and collections rules by requiring an itemized, layperson-friendly bill before referral to collections. It directs the State Auditor to review prices charged by State-funded health service facilities, updates prior authorization and utilization review rules for insurers, and requires faster and more detailed appeal and grievance disclosures. The bill further prohibits using an artificial intelligence-based algorithm as the sole basis for a utilization review denial and requires insurers to maintain a federally compliant prior authorization API.
A major structural change in the bill is the elimination of certificate-of-need review for inpatient rehabilitation services, rehabilitation facilities, and rehabilitation beds by redefining those terms in the CON statute. The bill also changes how out-of-network services are handled by restricting when insurers may apply out-of-network benefit levels and by requiring disclosure when network providers are not reasonably available. Several provisions apply to the State Health Plan as well, reflecting an intent to align State purchasing and utilization review practices with the new standards.
The general sentiment reflected in the bill text is strongly supportive of consumer price transparency, lower costs, and greater patient protection. The findings and preamble emphasize that high healthcare prices, surprise billing, and opaque facility fees burden patients, employers, and taxpayers, and the bill is framed as a response to those concerns. No committee transcript or recorded vote information was provided, so there is no additional evidence of debate or formal opposition in the supplied materials.
The main points of potential contention are likely to be the operational and financial impact on hospitals, ambulatory surgical facilities, insurers, and health systems, which would face new reporting, disclosure, and compliance obligations, as well as limits on facility fees and billing practices. Insurers and providers may also object to the good-faith estimate cap, the restrictions on prior authorization practices, the AI denial limitation, and the removal of CON review for rehabilitation services, all of which could affect utilization management, reimbursement, and market competition.
HB 434 would amend Chapter 131E, Chapter 58, and related statutes to impose new transparency, billing, collections, and reporting requirements on hospitals, ambulatory surgical facilities, health systems, insurers, and healthcare providers. It creates new statutory duties to disclose prices, network status, separate billing risks, facility fees, and good-faith estimates; authorizes penalties and unfair trade practice remedies for noncompliance; and requires DHHS, the Medical Care Commission, and the State Auditor to adopt rules or conduct reviews. It also changes the certificate-of-need framework by exempting inpatient rehabilitation services, rehabilitation facilities, and rehabilitation beds from CON review, and it updates utilization review and prior authorization rules for health benefit plans, including the State Health Plan.
The bill’s overall tone is consumer-protection oriented and strongly favorable to price transparency, affordability, and patient choice. Its findings repeatedly describe healthcare costs as excessive and opaque, and the bill is structured to reduce surprise billing, improve advance notice, and make prices easier to compare. Because no committee transcript or vote record was provided, the available context does not show specific floor or committee debate, but the text itself suggests a policy consensus around lowering costs while imposing stronger disclosure obligations on the healthcare industry.
The most likely areas of contention are the new compliance burdens and revenue constraints placed on hospitals, ambulatory surgical facilities, health systems, and insurers. Providers may object to mandatory public reporting of negotiated rates and facility-fee revenue, the 5% cap tied to good-faith estimates, restrictions on facility fees, and the requirement to provide detailed disclosures before treatment or collections. Insurers may also resist the tighter prior authorization timelines, the requirement to maintain an API, and the prohibition on using AI as the sole basis for denial. The elimination of certificate-of-need review for rehabilitation services may also be controversial because it could affect market entry, competition, and existing facility planning rules.